This inventor holds 3 USPTO granted patents and 1 published patent application, plus 1 CIPO patent and 1 EPO patent. Top assignee: The United States of America, as Represented by the Secretary, Department of Health and Human Services. Active years: 2019-2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2019-2026
Title: Janine Davis: Innovator in Retinal Research
Introduction
Janine Davis is a prominent inventor based in Baltimore, MD (US). She has made significant contributions to the field of retinal research, particularly in the generation of retinal pigment epithelium (RPE) cells from induced pluripotent stem cells (iPSCs). With a total of 3 patents, her work is paving the way for advancements in treatments for retinal diseases.
Latest Patents
Janine Davis holds two notable patents that focus on high-efficiency methods for producing retinal pigment epithelial cells from iPSCs. The first patent describes a method for generating RPE cells from iPSCs produced from somatic cells, including fetal RPE stem cells. This innovative approach includes the use of a tyrosinase promoter operably linked to a marker. The methods disclosed in her patents also cover the use of RPE cells for treatment and screening for agents that affect RPE differentiation.
Career Highlights
Janine Davis is affiliated with the National Institutes of Health, a component of the US Department of Health & Human Services. Her work at this esteemed institution has allowed her to focus on groundbreaking research that has the potential to impact the treatment of retinal diseases significantly.
Collaborations
Janine collaborates with notable colleagues, including Kapil Bharti and Arvydas Maminishkis. Their combined expertise enhances the research efforts in the field of retinal health and regenerative medicine.
Conclusion
Janine Davis is a trailblazer in the field of retinal research, with her innovative patents and collaborations contributing to significant advancements in medical science. Her work continues to inspire future research and development in the treatment of retinal diseases.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile